146 related articles for article (PubMed ID: 35400699)
1. Retroperitoneal Hemorrhage in Patients with COVID-19 Undergoing Hemodialysis: Three Case Reports.
Oka H; Homma Y; Nishino Y; Suemori K; Sato N; Sakurai Y; Sekimoto M; Ando S; Iwamoto S; Iwamoto T; Kondo M; Kamimura T; Nakano T; Kitazono T
Intern Med; 2022 Jun; 61(12):1869-1876. PubMed ID: 35400699
[TBL] [Abstract][Full Text] [Related]
2. Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
Lins PRG; de Albuquerque CCC; Assis CF; Rodrigues BCD; E Siqueira Campos BP; de Oliveira Valle E; Cabrera CPS; de Oliveira Gois J; Segura GC; Strufaldi FL; Mainardes LC; Ribeiro RG; Via Reque Cortes DDP; Lutf LG; de Oliveira MFA; Sales GTM; Smolentzov I; Reichert BV; Andrade L; Seabra VF; Rodrigues CE
Trials; 2020 Nov; 21(1):920. PubMed ID: 33176886
[TBL] [Abstract][Full Text] [Related]
3. Retroperitoneal hemorrhage in a patient with coronavirus disease 2019 (COVID-19):A case report.
Yoshioka T; Daizumoto K; Tada K; Mima M; Kagawa K; Fukawa T; Yamaguchi K; Takahashi M; Nishioka Y; Kanayama H
J Med Invest; 2022; 69(1.2):148-151. PubMed ID: 35466138
[TBL] [Abstract][Full Text] [Related]
4. Retroperitoneal Hematoma During Prophylactic Dose of Heparin Therapy for Coronavirus Disease 2019.
Okada N; Niimi K; Asami Y; Hattori S; Takiguchi H; Hayama N; Ito Y; Oguma T; Ono S; Asano K
Tokai J Exp Clin Med; 2023 Apr; 48(1):47-51. PubMed ID: 36999394
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous retroperitoneal bleeding: a case series.
Yamamura H; Morioka T; Yamamoto T; Kaneda K; Mizobata Y
BMC Res Notes; 2014 Sep; 7():659. PubMed ID: 25236774
[TBL] [Abstract][Full Text] [Related]
6. Bleeding Risk in Hemodialysis Patients.
van Eck van der Sluijs A; Pai P; Zhu W; Ocak G
Semin Nephrol; 2023 Nov; 43(6):151478. PubMed ID: 38238225
[TBL] [Abstract][Full Text] [Related]
7. Preventing hemorrhage in high-risk hemodialysis: regional versus low-dose heparin.
Swartz RD; Port FK
Kidney Int; 1979 Oct; 16(4):513-8. PubMed ID: 548596
[TBL] [Abstract][Full Text] [Related]
8. Superior outcome of nafamostat mesilate as an anticoagulant in patients undergoing maintenance hemodialysis with intracerebral hemorrhage.
Yang JW; Han BG; Kim BR; Lee YH; Kim YS; Yu JM; Choi SO
Ren Fail; 2009; 31(8):668-75. PubMed ID: 19814633
[TBL] [Abstract][Full Text] [Related]
9. Thromboelastography-Guided Anticoagulant Therapy for the Double Hazard of Thrombohemorrhagic Events in COVID-19: A Report of 3 Cases.
Bunch CM; Thomas AV; Stillson JE; Gillespie L; Lin KP; Speybroeck J; Kwaan HC; Fulkerson DH; Zamlut M; Khan R; Walsh MM
Am J Case Rep; 2021 Apr; 22():e931080. PubMed ID: 33883541
[TBL] [Abstract][Full Text] [Related]
10. Major bleeding in hemodialysis patients using unfractionated or low molecular weight heparin: a single-center study.
Nadarajah L; Fan S; Forbes S; Ashman N
Clin Nephrol; 2015 Nov; 84(5):274-9. PubMed ID: 26365216
[TBL] [Abstract][Full Text] [Related]
11. Use and safety of heparin-free maintenance hemodialysis in the USA.
Shen JI; Mitani AA; Chang TI; Winkelmayer WC
Nephrol Dial Transplant; 2013 Jun; 28(6):1589-602. PubMed ID: 23563280
[TBL] [Abstract][Full Text] [Related]
12. Heparin-induced thrombocytopenia in a hemodialysis patient treated with fondaparinux: nephrologists between two fires.
Solak Y; Demircioglu S; Polat I; Biyik Z; Gaipov A; Acar K; Turk S
Hemodial Int; 2013 Apr; 17(2):320-3. PubMed ID: 22631215
[TBL] [Abstract][Full Text] [Related]
13. [Improving outcome of COVID-19-associated thrombosis: the need for evaluation of fibrinolytic activation].
Yamada S; Asakura H
Rinsho Ketsueki; 2022; 63(5):471-480. PubMed ID: 35662173
[TBL] [Abstract][Full Text] [Related]
14. Influence of antiplatelet medications on bleeding events in hemodialysis patients.
Daimon S; Terai H
Ther Apher Dial; 2011 Oct; 15(5):454-9. PubMed ID: 21974698
[TBL] [Abstract][Full Text] [Related]
15. Nafamostat mesilate: a regional anticoagulant for hemodialysis in patients at high risk for bleeding.
Akizawa T; Koshikawa S; Ota K; Kazama M; Mimura N; Hirasawa Y
Nephron; 1993; 64(3):376-81. PubMed ID: 8341382
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous retroperitoneal hemorrhage after hemodialysis involving anticoagulant agents.
Fan WX; Deng ZX; Liu F; Liu RB; He L; Amrit B; Zang L; Li JW; Liu XR; Huang SM; Fu P
J Zhejiang Univ Sci B; 2012 May; 13(5):408-12. PubMed ID: 22556180
[TBL] [Abstract][Full Text] [Related]
17. Hemodialysis catheter heparin lock related bleeding: Hemorrhagic shock every other day.
Marques J; Duarte TI; Cotovio P; Borges A; Germano N
J Vasc Access; 2022 May; 23(3):455-457. PubMed ID: 33570006
[TBL] [Abstract][Full Text] [Related]
18. Heparin-free renal replacement therapy for chronic hemodialyzed patients at high risk for bleeding: a comparison of on-line predilution hemodiafiltration with conventional hemodialysis.
Brunot V; Serre JE; Mourad G; Klouche K; Pernin V
Hemodial Int; 2018 Oct; 22(4):463-473. PubMed ID: 29745004
[TBL] [Abstract][Full Text] [Related]
19. Systemic anticoagulation and bleeding in children with hemodialysis catheters.
Moritz ML; Vats A; Ellis D
Pediatr Nephrol; 2003 Jan; 18(1):68-70. PubMed ID: 12488995
[TBL] [Abstract][Full Text] [Related]
20. Dialysis circuit clotting in critically ill patients with COVID-19 infection.
Khoo BZE; Lim RS; See YP; Yeo SC
BMC Nephrol; 2021 Apr; 22(1):141. PubMed ID: 33879086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
